6-(1H-Imidazol-1-Yl)-2-Phenylquinazoline

The primary application of CR4056 lies in its potential as an analgesic agent for treating various pain conditions, including chronic pain syndromes and neuropathic pain. Its unique mechanism of action makes it a candidate for further development in pain management therapies, potentially providing alternatives to traditional opioid medications. Additionally, its neuroprotective effects open avenues for research into treatments for neurodegenerative diseases such as Alzheimer's disease.

The biological activity of CR4056 has been extensively studied, revealing its potent analgesic effects across several animal models of pain. It has demonstrated efficacy in reducing inflammatory and neuropathic pain, showing a synergistic effect when combined with opioids. Furthermore, CR4056 has been investigated for its neuroprotective properties, particularly in models of Alzheimer's disease, suggesting that it may also play a role in cognitive function improvement by modulating neurotransmitter systems.

Please email your required order quantity and detailed technical specifications to sales@.
Our sales team will promptly prepare an accurate quotation for your bulk order and provide a comprehensive pricing proposal.

All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.